LCA5L 抗体 (N-Term)
(1 reference)Quick Overview for LCA5L 抗体 (N-Term) (ABIN2782411)
抗原
适用
宿主
克隆类型
标记
应用范围
-
-
抗原表位
- N-Term
-
序列
- SLADLTKTNI DEHFFGVALE NNRRSAACKR SPGTGDFSRN SNASNKSVDY
-
预测反应
- Human: 100%, Yeast: 75%
-
产品特性
- This is a rabbit polyclonal antibody against C21orf13. It was validated on Western Blot using a cell lysate as a positive control.
-
纯化方法
- Affinity Purified
-
免疫原
- The immunogen is a synthetic peptide directed towards the N terminal region of human C21orf13
-
-
anti-Leber Congenital Amaurosis 5-Like (LCA5L) (AA 301-400) antibody
LCA5L 适用: 大鼠 IF (p), IF (cc), ELISA, IHC (p), IHC (fro), ICC 宿主: 兔 Polyclonal unconjugated
anti-Leber Congenital Amaurosis 5-Like (LCA5L) (C-Term) antibodyLCA5L 适用: 人, Cow, 猴, 犬 WB 宿主: 兔 Polyclonal unconjugated
anti-Leber Congenital Amaurosis 5-Like (LCA5L) (N-Term) antibodyLCA5L 适用: 人, 猴 WB 宿主: 兔 Polyclonal unconjugated
anti-Leber Congenital Amaurosis 5-Like (LCA5L) (N-Term) antibodyLCA5L 适用: 人 WB 宿主: 兔 Polyclonal unconjugated
anti-Leber Congenital Amaurosis 5-Like (LCA5L) (AA 380-408), (C-Term) antibodyLCA5L 适用: 人, 小鼠 WB, IHC (p) 宿主: 兔 Polyclonal RB27570 unconjugated
anti-Leber Congenital Amaurosis 5-Like (LCA5L) (AA 387-416), (C-Term) antibodyLCA5L 适用: 人, 小鼠 WB, IHC (p), EIA 宿主: 兔 Polyclonal unconjugated
-
-
应用备注
- Optimal working dilutions should be determined experimentally by the investigator.
-
说明
-
Antigen size: 670 AA
-
限制
- 仅限研究用
-
-
-
状态
- Liquid
-
浓度
- Lot specific
-
缓冲液
- Liquid. Purified antibody supplied in 1x PBS buffer with 0.09 % (w/v) sodium azide and 2 % sucrose.
-
储存液
- Sodium azide
-
注意事项
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
注意事项
- Avoid repeated freeze-thaw cycles.
-
储存条件
- -20 °C
-
储存方法
- For short term use, store at 2-8°C up to 1 week. For long term storage, store at -20°C in small aliquots to prevent freeze-thaw cycles.
-
-
-
: "Expression of trisomic proteins in Down syndrome model systems." in: Gene, Vol. 512, Issue 2, pp. 219-25, (2012) (PubMed).
-
: "Expression of trisomic proteins in Down syndrome model systems." in: Gene, Vol. 512, Issue 2, pp. 219-25, (2012) (PubMed).
-
-
